Yoshinori Kagawa Selected Research

Colorectal Neoplasms (Colorectal Cancer)

5/2024	Real-World Evidence of FOLFIRI Combined with Anti-Angiogenesis Inhibitors or Anti-EGFR Antibodies for Patients with Early Recurrence Colorectal Cancer After Adjuvant FOLFOX/CAPOX Therapy: A Japanese Claims Database Study.
4/2024	Curative resection via right hemicolectomy and regional lymph node dissection for colonic adenomatous polyposis of unknown etiology with adenocarcinomas localized in the right side of the colon: a case report.
8/2023	NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgically resectable BRAF V600E mutant colorectal oligometastases.
1/2023	Phase II dose titration study of regorafenib in progressive unresectable metastatic colorectal cancer.
1/2023	Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial.
1/2023	The Phase II Study of Panitumumab in Chemotherapy-Naïve Frail or Elderly Patients with RAS Wild-type Colorectal Cancer: OGSG 1602 Final Results.
1/2023	Role of plasma angiogenesis factors in the efficacy of first-line chemotherapy combined with biologics in RAS wild-type metastatic colorectal cancer: Results from the GI-SCREEN CRC-Ukit study.
1/2023	Efficacy of Targeted Trials and Signaling Pathway Landscape in Advanced Gastrointestinal Cancers From SCRUM-Japan GI-SCREEN: A Nationwide Genomic Profiling Program.
12/2022	Multicenter, single-arm, phase II study of the continuous use of panitumumab in combination with FOLFIRI after FOLFOX for RAS wild-type metastatic colorectal cancer: Exploratory sequential examination of acquired mutations in circulating cell-free DNA.
12/2022	TRESBIEN (OGSG 2101): encorafenib, binimetinib and cetuximab for early recurrent stage II/III BRAF V600E-mutated colorectal cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshinori Kagawa Research Topics

Disease

59	Neoplasms (Cancer) 07/2024 - 11/2008
43	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 11/2014
29	Neoplasm Metastasis (Metastasis) 03/2024 - 11/2009
23	Rectal Neoplasms (Rectal Cancer) 07/2024 - 11/2008
12	Stomach Neoplasms (Stomach Cancer) 07/2023 - 11/2015
9	Adenocarcinoma 04/2024 - 11/2014
9	Breast Neoplasms (Breast Cancer) 03/2020 - 11/2014
8	Colonic Neoplasms (Colon Cancer) 02/2023 - 01/2013
8	Pancreatic Neoplasms (Pancreatic Cancer) 04/2019 - 11/2013
7	Lymphatic Metastasis 01/2022 - 11/2010
6	Hepatocellular Carcinoma (Hepatoma) 02/2020 - 08/2014
5	Hemorrhage 07/2024 - 11/2014
5	Sigmoid Neoplasms 02/2023 - 11/2015
5	Carcinoma (Carcinomatosis) 02/2023 - 11/2013
5	Neutropenia 01/2023 - 01/2018
4	Esophageal Neoplasms (Esophageal Cancer) 02/2024 - 07/2013
4	Abscess 11/2023 - 11/2015
4	Mucinous Adenocarcinoma (Mucinous Carcinoma) 10/2020 - 02/2018
3	Infections 03/2019 - 11/2015
3	Disease Progression 12/2018 - 11/2013
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023 - 12/2020
2	Surgical Wound Infection 01/2022 - 11/2017
2	Wounds and Injuries (Trauma) 01/2022 - 12/2020
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2021 - 11/2017
2	Carcinoid Tumor (Carcinoid) 02/2021 - 11/2015
2	Enteritis 12/2020 - 11/2017
2	Neoplasms, Cystic, Mucinous, and Serous 10/2020 - 04/2020
2	Obstructive Jaundice (Cholestatic Jaundice) 12/2019 - 11/2014
2	Fibrosis (Cirrhosis) 03/2019 - 11/2014
2	Pathologic Constriction (Stenosis) 12/2018 - 11/2014
2	Fever (Fevers) 12/2018 - 02/2018
2	Liver Failure 11/2017 - 11/2016
2	Cholangitis 11/2017 - 11/2013
2	Diarrhea 11/2015 - 11/2013
1	Intraoperative Complications 07/2024
1	Obesity 07/2024

Drug/Important Bio-Agent (IBA)

11	Bevacizumab (Avastin)FDA Link 01/2023 - 11/2017
9	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2024 - 11/2014
9	Cetuximab (Erbitux)FDA Link 12/2023 - 11/2014
9	Cisplatin (Platino)FDA LinkGeneric 12/2019 - 11/2013
8	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 11/2010
7	Fluorouracil (Carac)FDA LinkGeneric 05/2024 - 11/2014
7	Panitumumab (Vectibix)FDA Link 01/2023 - 01/2021
6	Capecitabine (Xeloda)FDA Link 05/2024 - 11/2016
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2014
6	Estrogen ReceptorsIBA 12/2019 - 11/2014
6	Progesterone Receptors (Progesterone Receptor)IBA 12/2019 - 11/2014
5	Gemcitabine FDA Link 12/2019 - 11/2013
4	Leucovorin (Folinic Acid)FDA Link 05/2024 - 11/2010
4	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 08/2003
4	trifluridine tipiracil drug combinationIBA 01/2023 - 01/2020
4	ErbB Receptors (EGF Receptor)IBA 01/2022 - 06/2021
4	Trastuzumab (Herceptin)FDA Link 12/2018 - 11/2015
3	Trinitrotoluene (TNT)IBA 03/2024 - 02/2023
3	Monoclonal AntibodiesIBA 01/2022 - 06/2021
3	RamucirumabIBA 11/2021 - 03/2020
3	Indicators and Reagents (Reagents)IBA 10/2020 - 01/2013
3	130-nm albumin-bound paclitaxelIBA 03/2020 - 11/2015
3	human ERBB2 proteinIBA 11/2014 - 11/2014
2	AntibodiesIBA 05/2024 - 08/2003
2	encorafenibIBA 08/2023 - 12/2022
2	binimetinibIBA 08/2023 - 12/2022
2	regorafenibIBA 01/2023 - 11/2014
2	XELOXIBA 04/2022 - 01/2018
2	Circulating Tumor DNAIBA 01/2022 - 12/2020
2	afliberceptIBA 01/2021 - 12/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2020 - 11/2016
2	Hormones (Hormone)IBA 03/2019 - 11/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2018 - 11/2016
2	Phosphotransferases (Kinase)IBA 01/2018 - 11/2014
2	folfirinoxIBA 11/2017 - 11/2015
2	titanium silicide (TS-1)IBA 11/2016 - 11/2015
2	MicroRNAs (MicroRNA)IBA 09/2015 - 12/2014

Therapy/Procedure

52	Drug Therapy (Chemotherapy) 03/2024 - 11/2010
35	Therapeutics 05/2024 - 11/2008
16	Lymph Node Excision (Lymph Node Dissection) 04/2024 - 11/2014
11	Neoadjuvant Therapy 03/2024 - 11/2013
11	Gastrectomy 07/2023 - 11/2015
9	Colectomy 05/2024 - 11/2014
7	Hepatectomy 12/2023 - 11/2014
7	Pancreatectomy 12/2021 - 11/2015
6	Chemoradiotherapy 03/2024 - 11/2015
6	Adjuvant Chemotherapy 12/2022 - 08/2017
6	Stents 12/2018 - 11/2014
5	Laparotomy 07/2024 - 12/2016
5	Radiotherapy 03/2024 - 11/2010
4	Cholecystectomy 02/2022 - 11/2015
4	Mastectomy (Mammectomy) 03/2020 - 11/2014
3	Operative Time 07/2024 - 11/2015
3	Pancreaticoduodenectomy 12/2021 - 11/2014
3	Proctectomy 03/2020 - 11/2016
3	Segmental Mastectomy (Lumpectomy) 03/2020 - 11/2014
2	Esophagectomy 02/2024 - 01/2021
2	Renal Dialysis (Hemodialysis) 12/2021 - 11/2015
2	Decompression 09/2021 - 12/2016
2	Catheters 02/2021 - 12/2016
2	Combination Drug Therapy (Combination Chemotherapy) 12/2019 - 11/2015
2	Pelvic Exenteration 11/2017 - 11/2011
2	Splenectomy 11/2017 - 11/2015
2	Induction Chemotherapy 11/2017 - 05/2015